Compare Stocks: SMLR, AORT, PRCT, and STAA

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$25.13 +1.9%	$26.25	$19.16 ▼ $48.25	$1.23B	1.25	599,093 shs	547,889 shs
PRCT PROCEPT BioRobotics	$20.39 +1.6%	$20.26	$16.67 ▼ $40.10	$1.17B	0.91	1.55 million shs	1.57 million shs
SMLR Semler Scientific	$20.33 -4.9%	$19.24	$14.89 ▼ $50.44	$310.74M	1.32	895,814 shs	1.62 million shs
STAA STAAR Surgical	$22.66 -3.2%	$24.66	$15.59 ▼ $35.87	$1.14B	1.21	1.15 million shs	838,686 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	-2.36%	-3.88%	-13.56%	+22.80%	-39.95%
PRCT PROCEPT BioRobotics	-3.23%	-6.08%	-12.32%	-21.91%	-46.48%
SMLR Semler Scientific	0.00%	0.00%	0.00%	0.00%	-27.44%
STAA STAAR Surgical	-0.85%	-0.68%	-6.09%	-17.45%	-15.33%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AORT Artivion	$25.13 +1.9%	$26.25	$19.16 ▼ $48.25	$1.23B	1.25	599,093 shs	547,889 shs
PRCT PROCEPT BioRobotics	$20.39 +1.6%	$20.26	$16.67 ▼ $40.10	$1.17B	0.91	1.55 million shs	1.57 million shs
SMLR Semler Scientific	$20.33 -4.9%	$19.24	$14.89 ▼ $50.44	$310.74M	1.32	895,814 shs	1.62 million shs
STAA STAAR Surgical	$22.66 -3.2%	$24.66	$15.59 ▼ $35.87	$1.14B	1.21	1.15 million shs	838,686 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AORT Artivion	-2.36%	-3.88%	-13.56%	+22.80%	-39.95%
PRCT PROCEPT BioRobotics	-3.23%	-6.08%	-12.32%	-21.91%	-46.48%
SMLR Semler Scientific	0.00%	0.00%	0.00%	0.00%	-27.44%
STAA STAAR Surgical	-0.85%	-0.68%	-6.09%	-17.45%	-15.33%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AORT Artivion	2.75	Moderate Buy	$44.83	78.42% Upside
PRCT PROCEPT BioRobotics	2.19	Hold	$25.09	23.05% Upside
SMLR Semler Scientific	2.67	Moderate Buy	$83.00	308.26% Upside
STAA STAAR Surgical	1.92	Reduce	$28.40	25.33% Upside

Current Analyst Ratings Breakdown

Latest SMLR, AORT, PRCT, and STAA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	PRCT PROCEPT BioRobotics	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform
9/2/2026	STAA STAAR Surgical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/18/2026	AORT Artivion	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$39.00 ➝ $40.00
8/17/2026	STAA STAAR Surgical	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$28.00
8/17/2026	STAA STAAR Surgical	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$31.00 ➝ $28.00
8/13/2026	STAA STAAR Surgical	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$28.00
8/13/2026	STAA STAAR Surgical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D+)
8/13/2026	STAA STAAR Surgical	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$33.00
8/13/2026	STAA STAAR Surgical	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
8/13/2026	STAA STAAR Surgical	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Sell	$20.00 ➝ $19.00
8/13/2026	STAA STAAR Surgical	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$40.00 ➝ $37.00

(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AORT Artivion	$441.33M	2.78	$1.10 per share	22.89	$9.46 per share	2.66
PRCT PROCEPT BioRobotics	$308.05M	3.79	N/A	N/A	$6.55 per share	3.11
SMLR Semler Scientific	$36.96M	8.41	$4.48 per share	4.54	$24.90 per share	0.82
STAA STAAR Surgical	$239.44M	4.75	N/A	N/A	$6.92 per share	3.27

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AORT Artivion	$9.77M	-$0.07	N/A	32.63	N/A	-0.67%	6.07%	2.93%	11/5/2026 (Estimated)
PRCT PROCEPT BioRobotics	-$95.57M	-$1.94	N/A	N/A	N/A	-32.53%	-30.62%	-22.10%	11/3/2026 (Estimated)
SMLR Semler Scientific	$40.90M	$2.78	7.31	N/A	N/A	130.80%	34.21%	25.58%	N/A
STAA STAAR Surgical	-$80.45M	$0.07	323.76	41.96	N/A	1.13%	9.05%	6.99%	11/4/2026 (Estimated)

Latest SMLR, AORT, PRCT, and STAA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	STAA STAAR Surgical	$0.2214	$0.39	+$0.1686	$0.16	$90.60 million	$93.54 million
8/6/2026	Q2 2026	AORT Artivion	$0.0025	$0.13	+$0.1275	-$0.28	$119.99 million	$125.76 million
8/4/2026	Q2 2026	PRCT PROCEPT BioRobotics	-$0.4619	-$0.47	-$0.0081	-$0.47	$92.77 million	$94.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AORT Artivion	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
SMLR Semler Scientific	N/A	N/A	N/A	N/A	N/A
STAA STAAR Surgical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AORT Artivion	0.82	3.47	2.51
PRCT PROCEPT BioRobotics	0.15	6.55	5.35
SMLR Semler Scientific	0.21	1.97	1.95
STAA STAAR Surgical	N/A	4.66	4.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AORT Artivion	86.37%
PRCT PROCEPT BioRobotics	89.46%
SMLR Semler Scientific	49.37%
STAA STAAR Surgical	96.70%

Insider Ownership

Company	Insider Ownership
AORT Artivion	6.30%
PRCT PROCEPT BioRobotics	4.00%
SMLR Semler Scientific	16.40%
STAA STAAR Surgical	39.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AORT Artivion	1,800	48.76 million	45.68 million	Optionable
PRCT PROCEPT BioRobotics	430	57.27 million	54.98 million	Optionable
SMLR Semler Scientific	120	15.29 million	12.78 million	Not Optionable
STAA STAAR Surgical	1,211	50.14 million	30.14 million	Optionable

SMLR, AORT, PRCT, and STAA Headlines

Recent News About These Companies

STAAR Surgical (NASDAQ:STAA) Stock Price Down 5.2% - Here's What Happened

2 hours ago | marketbeat.com

STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction

September 10 at 8:34 AM | finance.yahoo.com

Staar Surgical Reappoints David Bailey to Drive Growth

September 10 at 6:51 AM | tipranks.com

STAAR Surgical Rehires Former CEO David Bailey as Chief Commercial Officer

September 10 at 3:33 AM | visionmonday.comV

STAAR Surgical Appoints David Bailey as Chief Commercial Officer

September 8 at 8:21 PM | marketscreener.comM

Staar Surgical Brings Back Former CEO Bailey as Commercial Chief

September 8 at 8:21 PM | marketwatch.com

STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer

September 8 at 8:21 PM | finance.yahoo.com

Zacks Research Downgrades STAAR Surgical (NASDAQ:STAA) to Hold

September 4, 2026 | marketbeat.com

Bank of New York Mellon Corp Invests $6.58 Million in STAAR Surgical Company $STAA

September 4, 2026 | marketbeat.com

STAAR Surgical Appoints Ben Park as Chief Technology Officer

September 2, 2026 | marketscreener.comM

STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer

September 2, 2026 | finance.yahoo.com

STAAR Surgical (NASDAQ:STAA) Trading Up 5.4% - Here's What Happened

September 1, 2026 | marketbeat.com

STAAR Surgical Company (NASDAQ:STAA) Receives Consensus Rating of "Hold" from Brokerages

August 29, 2026 | marketbeat.com

Staar Surgical Targets Presbyopia Growth With New Trifocal ICL Trial

August 27, 2026 | tipranks.com

Staar Surgical Advances Next‑Gen ICL Study, Signaling Long‑Term Growth Potential

August 27, 2026 | tipranks.com

American Capital Management Inc. Makes New $24.29 Million Investment in STAAR Surgical Company $STAA

August 27, 2026 | marketbeat.com

5 insightful analyst questions from STAAR Surgical’s Q2 earnings call

August 20, 2026 | msn.com

Why STAAR Surgical (STAA) shares are sliding today

August 17, 2026 | msn.com

Why STAAR Surgical (STAA) Is Up 8.1% After Q2 Profit Rebound And New CEO Appointment

August 17, 2026 | uk.finance.yahoo.com

STAAR Surgical (NASDAQ:STAA) Shares Down 6.6% Following Analyst Downgrade

August 17, 2026 | marketbeat.com

Deciphering Staar Surgical (STAA) International Revenue Trends

August 17, 2026 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMLR, AORT, PRCT, and STAA Company Descriptions

Artivion NYSE:AORT

$25.13 +0.48 (+1.94%)

Closing price 03:58 PM Eastern

Extended Trading

$25.08 -0.05 (-0.19%)

As of 04:28 PM Eastern

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

PROCEPT BioRobotics NASDAQ:PRCT

$20.39 +0.32 (+1.59%)

Closing price 04:00 PM Eastern

Extended Trading

$20.38 -0.02 (-0.07%)

As of 04:27 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Semler Scientific NASDAQ:SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

STAAR Surgical NASDAQ:STAA

$22.66 -0.76 (-3.25%)

Closing price 04:00 PM Eastern

Extended Trading

$22.66 0.00 (-0.02%)

As of 04:10 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SMLR, AORT, PRCT, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SMLR, AORT, PRCT, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SMLR, AORT, PRCT, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMLR, AORT, PRCT, and STAA Company Descriptions

Artivion NYSE:AORT

PROCEPT BioRobotics NASDAQ:PRCT

Semler Scientific NASDAQ:SMLR

STAAR Surgical NASDAQ:STAA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SMLR, AORT, PRCT, and STAA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SMLR, AORT, PRCT, and STAA Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SMLR, AORT, PRCT, and STAA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMLR, AORT, PRCT, and STAA Company Descriptions

Artivion NYSE:AORT

PROCEPT BioRobotics NASDAQ:PRCT

Semler Scientific NASDAQ:SMLR

STAAR Surgical NASDAQ:STAA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools